MoonLake Immunotherapeutics
Price & Volume
Stats
See moreOpen | $19.37 |
Previous Close | $19.41 |
Day Range | $17.95-$19.57 |
52W Range | $5.95-$62.75 |
Market Cap | $1.3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.68 |
News
See moreYahoo Finance • 4 days ago
Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares
Yahoo Finance • 14 days ago
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Yahoo Finance • 23 days ago
Micron downgraded, Five Below upgraded: Wall Street's top analyst calls
Yahoo Finance • last month
Goldman Questions MoonLake Immunotherapeutics’ (MLTX) Sonelokimab Approval Odds Despite Pipeline Update
About
CEO | Dr. Jorge Santos da Silva Ph.D. |
Address | Dorfstrasse 29, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
